Community-associated MRSA in the pediatric primary care setting.
Community-associated methicillin-resistant (CA-MRSA) infections occur in children throughout the United States and worldwide. The most common are skin and soft tissue infections. However, life-threatening invasive disease and death can occur as a result of CA-MRSA. The rising prevalence of antimicrobial resistance associated with CA-MRSA further complicates antibiotic treatment therapy. This clinical paper elucidates the recent evolution in the epidemiology of CA-MRSA in otherwise healthy children within the community, and the rising antimicrobial resistance of this virulent pathogen. Furthermore, it will focus on the importance of timely diagnosis, treatment, and management of the most common presenting pediatric infections seen in the outpatient setting. The current Centers for Disease Control and Prevention (CDC) clinical management strategies identify the optimal prevention and treatment approach to be used by pediatric primary care providers.
Hinckley
June
J
Yale University School of Nursing, New Haven, CT, USA.
Allen
Patricia Jackson
PJ
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002675:Child, Preschool; D002981:Clindamycin / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000175:diagnosis* / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy*; D018718:Home Infusion Therapy; D006801:Humans; D008297:Male; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D009722:Nurse Practitioners / Q000458:organization & administration; D024802:Nurse's Role; D009730:Nursing Assessment; D010349:Patient Compliance; D010371:Pediatric Nursing / Q000458:organization & administration; D015995:Prevalence; D011320:Primary Health Care / Q000458:organization & administration*; D012307:Risk Factors; D013207:Staphylococcal Skin Infections / Q000175:diagnosis* / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy*; D013211:Staphylococcus aureus; D014481:United States / Q000453:epidemiology
D000900:Anti-Bacterial Agents; D002981:Clindamycin